𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hemolytic-Uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha

✍ Scribed by Daniel Schlaifer; Philippe Dumazer; Nathalie Spenatto; Madeleine Mignon-Conte; Pierre Brousset; Catherine Lumbroso; Mike Cooper; Catherine Muller; Françoise Huguet; Michel Attal; Guy Laurent; Jacques Pris

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
243 KB
Volume
47
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cutaneous sarcoidosis in a patient with
Cutaneous sarcoidosis in a patient with philadelphia-positive chronic myelogenous leukemia treated with interferon-α
✍ Yavorkovsky, Leonid L.; Carrum, George; Bruce, Suzanne; McCarthy, Philip L. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 17 KB 👁 1 views

A patient with Philadelphia-positive (Ph+) chronic myelogenous leukemia (CML) was diagnosed with cutaneous sarcoidosis after treatment with interferon-alpha (IFN-␣). Following IFN-␣ dose reduction, the skin lesions disappeared. Few cases of sarcoidosis associated with IFN treatment have been reporte

A review of hemolytic uremic syndrome in
A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
✍ Man C. Fung; Anna Maria Storniolo; Binh Nguyen; Michael Arning; William Brookfie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## BACKGROUND. Hemolytic uremic syndrome (HUS) is a rare condition that occasionally is reported in cancer patients. Recently it has been observed that gemcitabine rarely may be associated with this condition. METHODS. The manufacturer's safety database and literature were reviewed for any report

Severe autoimmune hepatitis in a chronic
Severe autoimmune hepatitis in a chronic myeloid leukemia patient treated with interferon alpha and with complete genetic response
✍ Steegmann, Juan Luis; Requena, María José; García-Buey, María Luisa; Granados, E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 1 views

A patient with chronic myeloid leukemia (CML) treated with interferon alpha (IFN alpha) and who developed autoimmune hepatitis (AIH) is described. The patient was treated with IFN alpha 2a, a complete cytogenetic response was achieved 5 months later, and this response has lasted now more than 7 year